US Stock MarketDetailed Quotes
SONN Sonnet BioTherapeutic
- 2.9800
- +0.0900+3.11%
Close Nov 22 16:00 ET
- 2.9500
- -0.0300-1.01%
Post 20:01 ET
2.50MMarket Cap-3104P/E (TTM)
3.0000High2.8800Low45.44KVolume2.8800Open2.8900Pre Close134.00KTurnover5.73%Turnover RatioLossP/E (Static)837.66KShares18.719252wk High0.95P/B2.36MFloat Cap2.500052wk Low--Dividend TTM792.44KShs Float329609.2800Historical High--Div YieldTTM4.15%Amplitude2.5000Historical Low2.9490Avg Price1Lot Size
Sonnet BioTherapeutic Key Stats
EPS
According to the latest financial report of Sonnet BioTherapeutic, the latest earnings per share (TTM) for the company is -5.60. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Sonnet BioTherapeutic's free cash flow? The latest report shows it as -3.08M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Sonnet BioTherapeutic shows that the company's current ratio is 1.65, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Sonnet BioTherapeutic, the quick ratio is 1.31, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Sonnet BioTherapeutic? The latest ROE figure is -123.60%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Sonnet BioTherapeutic, the total asset return on investment (ROA) is -59.89%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Sonnet BioTherapeutic's latest financial report to see how their gross margin is doing - currently at 68.36%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Sonnet BioTherapeutic, the net profit margin is -6.27K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data